Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBEC

14 Mar 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Molecular Biology Techniques and Applications

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40090261
DOI: 10.1016/j.lungcan.2025.108487

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBECPMID 40090261Read ↗

Targeting APOBECs in cancer: It’s about timingSemantic proximity Read ↗

Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.Semantic proximity Read ↗

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistanceSemantic proximity Read ↗

Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease.Semantic proximity Read ↗

Targeting ALK: Precision Medicine Takes on Drug Resistance.Semantic proximity Read ↗

Mathematical Model of Intrinsic Drug Resistance in Lung Cancer.Semantic proximity Read ↗

Mouse avatars of human cancers: the temporality of translation in precision oncologySemantic proximity Read ↗

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancerSemantic proximity Read ↗

APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancerSemantic proximity Read ↗

APOBEC3 genes: retroviral restriction factors to cancer driversSemantic proximity Read ↗

Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers.Semantic proximity Read ↗

APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.